Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$16,734,289
-$272,732 QoQ
Shares Held
46,212
-4.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#418
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. AMGN ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
This page
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,734,289 | 46,212 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $17,007,021 | 48,336 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $15,977,309 | 48,814 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $13,805,223 | 48,920 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $13,697,204 | 49,057 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $15,337,917 | 49,231 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $12,743,210 | 48,892 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $10,443,148 | 32,411 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $10,054,327 | 32,179 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $9,229,880 | 32,463 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $9,397,803 | 32,629 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $8,146,383 | 30,311 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $6,088,231 | 27,422 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $6,711,463 | 27,762 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $7,505,988 | 28,579 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $6,569,507 | 29,146 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $7,052,537 | 28,987 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $6,840,604 | 28,288 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,957,429 | 26,481 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $5,524,221 | 25,978 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $6,327,735 | 25,432 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $5,729,605 | 24,920 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,872,366 | 23,105 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $5,401,194 | 22,900 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,478,913 | 22,093 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||